These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vascular smooth muscle function and its changes in hypertension. Bohr DF; Webb RC Am J Med; 1984 Oct; 77(4A):3-16. PubMed ID: 6091449 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity of caudal arteries and the mesenteric vascular bed to norepinephrine in DOCA-salt hypertension. Longhurst PA; Rice PJ; Taylor DA; Fleming WW Hypertension; 1988 Aug; 12(2):133-42. PubMed ID: 3410523 [TBL] [Abstract][Full Text] [Related]
7. Is calcium more important than sodium in the pathogenesis of essential hypertension? McCarron DA Hypertension; 1985; 7(4):607-27. PubMed ID: 3891618 [TBL] [Abstract][Full Text] [Related]
8. Norepinephrine sensitivity and membrane potentials of caudal arterial muscle in DOCA-salt, Dahl, and SHR hypertension in rat. Hermsmeyer K; Abel PW; Trapani AJ Hypertension; 1982; 4(3 Pt 2):49-51. PubMed ID: 6279507 [TBL] [Abstract][Full Text] [Related]
10. [Pathogenetic importance of disturbed cell membrane function in hypertension]. Postnov IuV Kardiologiia; 1981 Jul; 21(7):5-12. PubMed ID: 7024617 [No Abstract] [Full Text] [Related]
11. Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats. Hefti F; Gerold M; Holck M J Cardiovasc Pharmacol; 1984; 6(6):1192-200. PubMed ID: 6084779 [TBL] [Abstract][Full Text] [Related]
12. Sodium pump activity and norepinephrine responsiveness of femoral arterial smooth muscle from DOCA-salt rats. Soltis EE; Field FP Pharmacology; 1987; 34(2-3):104-10. PubMed ID: 3588654 [TBL] [Abstract][Full Text] [Related]
13. Effect of isoflurane on in situ vascular smooth muscle transmembrane potential in spontaneous hypertension. Stekiel TA; Kokita N; Yamazaki M; Bosnjak ZJ; Kampine JP; Stekiel WJ Anesthesiology; 1999 Jul; 91(1):207-14. PubMed ID: 10422946 [TBL] [Abstract][Full Text] [Related]
14. The etiopathology of hypertension. Siegenthaler W; Werning C Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):83-92. PubMed ID: 4321984 [No Abstract] [Full Text] [Related]
15. Vasopressin-central nervous system interactions in the development of DOCA hypertension. Berecek KH; Barron KW; Webb RL; Brody MJ Hypertension; 1982; 4(3 Pt 2):131-7. PubMed ID: 7068203 [TBL] [Abstract][Full Text] [Related]
16. Abnormal biochemistry of vascular smooth muscle plasma membrane isolated from hypertensive rats. Kwan CY; Belbeck L; Daniel EE Mol Pharmacol; 1980 Jan; 17(1):137-40. PubMed ID: 7383016 [No Abstract] [Full Text] [Related]
18. Membrane mechanisms in arterial hypertension. Harder DR; Hermsmeyer K Hypertension; 1983; 5(4):404-8. PubMed ID: 6345356 [TBL] [Abstract][Full Text] [Related]
19. Arterial receptors for adrenal steroids and transport of electrolytes in vascular smooth muscle. Kornel L; Rafelson ME; Hayashi T; Kanamarlapudi N; Anderson KM Clin Physiol Biochem; 1988; 6(3-4):188-200. PubMed ID: 2849520 [TBL] [Abstract][Full Text] [Related]
20. Role of cardiovascular phospholipase A2 and C in the development of DOCA-salt hypertensive rats. Uehara Y; Numabe A; Ishimitsu T; Ishii M; Yagi S Adv Exp Med Biol; 1989; 247A():231-6. PubMed ID: 2603789 [No Abstract] [Full Text] [Related] [Next] [New Search]